A Finnish diagnostics company is looking for distributors for acute infections diagnostic products

A Finnish SME, established 2005, develops and manufactures high quality diagnostic products and services especially for multianalyte and rapid diagnostics of acute infections. The unique platform enables automated and decentralised syndromic testing and health security screening of acute infections. The test panels cover viruses and bacteria for most common acute infections such as respiratory, pharyngitis and gastrointestinal infections. The streptococcous tests are the most sensitive in the world.

The SME already exports to 15 countries globally, but it pursues new markets, more extensive distributor network, and fast growth. In its domestic market in Finland, the SME is a clear market leader in its own segment. 75% of the largest Finnish private healthcare providers rely on the SME’s service and technology. The technology is field proven, with high customer satisfaction. The product is the most sophisticated solution in the market for automated multidisease testing of acute infections.

The company has the following products:

1. A multianalyte test for acute upper and lower respiratory tract infections. The test system enables rapid detection and differentiation between viral and bacterial infections. (20 min preliminary result, 2 h final results).

2. A test for acute pharyngitis and tonsillitis. One can decide to choose a single analyte test, that reports results in 15 min with equal sensitivity to standard culture.

3. A multianalyte test for testing of acute gastroenteritis. The test system allows to run Gastro test and CDI (Clostridium difficile infection) test from the same patient sample.

4. CDI (Clostridium difficile infection) test is designed to follow the ESCMID (European Society of Clinical Microbiology and Infectious Diseases) guideline for Clostridium difficile diagnostics. It allows simultaneous detection of the bacterium as well as the toxins A and B.

The company is looking for large and middle-size in vitro diagnostics companies to become new distributors and partners for localisation.

POD reference: BOFI20260210018